Profile
Marc L.
de Somer formerly worked at Galderma International SAS, as Executive Director, Alkermes, Inc., as Vice President-Clinical Research & Development, Cita NeuroPharmaceuticals, Inc., as Executive Vice President-Research & Development, Cervelo Pharmaceuticals Ltd., as Chief Medical Officer, EVP-Research & Development in 2009, Voyager Therapeutics, Inc., as Vice President-Clinical Research & Development, Relmada Therapeutics, Inc., as Senior Vice President-Clinical Development from 2020 to 2022, and PPD, Inc., as Vice President-Neurology.
Dr. de Somer received his graduate degree and Masters Business Admin degree from Harvard University, doctorate degree from Université Libre de Bruxelles, doctorate degree from Instituut voor Tropische Geneeskunde, and Masters Business Admin degree from Columbia Business School.
Former positions of Marc L. de Somer
| Companies | Position | End |
|---|---|---|
| RELMADA THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2022-10-31 |
Cervelo Pharmaceuticals Ltd.
 Cervelo Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Cervelo Pharmaceuticals Ltd. engages in the preparation of pharmaceuticals. It develops drug product candidates for neuropathic, inflammatory, and neurodegenerative diseases. The company was founded by Anthony J. Giovinazzo in 2006 and is headquartered in Mississauga, Canada. | Chief Tech/Sci/R&D Officer | 2009-12-14 |
Cita NeuroPharmaceuticals, Inc.
 Cita NeuroPharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cita Neuro Pharmaceuticals, Inc. develops and commercializes small molecule drugs. Its clinical drug portfolio consists of drugs for Parkinson's disease and neuropathic pain. Cita Neuro Pharmaceuticals was founded in 1997 by Brian Bennett, Roland Boegman, Khem Jha-mandas, James Reynolds and Gregory Thatcher and is headquartered in Mississauga, Canada. | Chief Tech/Sci/R&D Officer | - |
| PPD, INC. | Corporate Officer/Principal | - |
Alkermes, Inc.
 Alkermes, Inc. Pharmaceuticals: MajorHealth Technology Alkermes, Inc. develops and manufactures pharmaceutical products. It offers medicines for the treatment of central nervous system (CNS) diseases. The company was founded by Michael A. Wall, Floyd E. Bloom, Frederick W. K. Brown, Paul R. Schimmel and Alexander G. Rich in 1987 and is headquartered in Waltham, MA. | Corporate Officer/Principal | - |
Training of Marc L. de Somer
| Université Libre de Bruxelles | Doctorate Degree |
| Harvard University | Graduate Degree |
| Instituut voor Tropische Geneeskunde | Doctorate Degree |
| Columbia Business School | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| RELMADA THERAPEUTICS, INC. | Health Technology |
| VOYAGER THERAPEUTICS, INC. | Health Technology |
| Private companies | 5 |
|---|---|
Cervelo Pharmaceuticals Ltd.
Cervelo Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Cervelo Pharmaceuticals Ltd. engages in the preparation of pharmaceuticals. It develops drug product candidates for neuropathic, inflammatory, and neurodegenerative diseases. The company was founded by Anthony J. Giovinazzo in 2006 and is headquartered in Mississauga, Canada. | Health Technology |
Cita NeuroPharmaceuticals, Inc.
Cita NeuroPharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cita Neuro Pharmaceuticals, Inc. develops and commercializes small molecule drugs. Its clinical drug portfolio consists of drugs for Parkinson's disease and neuropathic pain. Cita Neuro Pharmaceuticals was founded in 1997 by Brian Bennett, Roland Boegman, Khem Jha-mandas, James Reynolds and Gregory Thatcher and is headquartered in Mississauga, Canada. | Health Technology |
Galderma International SAS
 Galderma International SAS Pharmaceuticals: MajorHealth Technology Galderma SA develops and markets therapeutic and aesthetic solutions for dermatology. It provides medical dermatological solutions for acne, rosacea, psoriasis and other steroid-responsive dermatoses, onychomycosis, pigmentary disorders, skin cancer and medical aesthetic and corrective solutions for skin senescence. The company was founded in 1981 and is headquartered in Paris, France. | Health Technology |
Alkermes, Inc.
Alkermes, Inc. Pharmaceuticals: MajorHealth Technology Alkermes, Inc. develops and manufactures pharmaceutical products. It offers medicines for the treatment of central nervous system (CNS) diseases. The company was founded by Michael A. Wall, Floyd E. Bloom, Frederick W. K. Brown, Paul R. Schimmel and Alexander G. Rich in 1987 and is headquartered in Waltham, MA. | Health Technology |
PPD, Inc.
 PPD, Inc. Miscellaneous Commercial ServicesCommercial Services PPD, Inc. engages in the provision of drug development services to the biopharmaceutical industry, focuses on helping customers bring their new medicines to patients around the world. It operates through the Clinical Development Services and Laboratory Services segments. The Clinical Development Services segment focuses in early development/Phase I, patient recruitment and enrollment, investigator site management, Phase II-IV clinical trial management, medical communications and various peri- and post-approval services. The Laboratory Services segment comprises of bioanalytical, vaccine sciences, GMP, central lab and biomarker testing. The company was founded by Fred Eshelma in 1985 and is headquartered in Wilmington, NC. | Commercial Services |
- Stock Market
- Insiders
- Marc L. de Somer
